Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives

Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives

Phosphodiesterase 5 (PDE5) inhibitors presented themselves as important players in the nitric oxide/cGMP pathway, thus exerting a profound impact on various physiological and pathological processes. Beyond their well-known efficacy in treating male erectile dysfunction (ED) and pulmonary arterial hy...

Full description

Bibliographic Details
Main Authors: Ahmed K. ElHady, Dalia S. El-Gamil, Mohammad Abdel-Halim, Ashraf H. Abadi
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Pharmaceuticals
Subjects:
phosphodiesterase 5 inhibitors
selectivity
NO/cGMP
erectile dysfunction
pulmonary arterial hypertension
Online Access:https://www.mdpi.com/1424-8247/16/9/1266

Internet

https://www.mdpi.com/1424-8247/16/9/1266

Similar Items